CNBX Pharmaceuticals Inc. (CNBX) Long-Term Deferred Tax (2022 - 2024)
CNBX Pharmaceuticals' (CNBX) quarterly Long-Term Deferred Tax came in at $3.5 million in Q3 2024, down 35.58% on a QoQ basis from $5.4 million in Q3 2022.
CNBX Pharmaceuticals Inc. (CNBX) Long-Term Deferred Tax (2022 - 2024) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 2 years of Long-Term Deferred Tax data on file, last reported at $3.5 million in Q3 2024.
- Quarterly Long-Term Deferred Tax changed N/A year-over-year to $3.5 million in Q3 2024, while the trailing twelve-month figure through Aug 2024 was $3.5 million (changed N/A YoY) and the FY2024 annual result came in at $3.5 million, changed N/A from the prior year.
- Long-Term Deferred Tax fell to $3.5 million in Q3 2024, from $5.4 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $5.4 million in Q3 2022 to a low of $3.5 million in Q3 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2024 | 3.47 Mn |
| Aug 31, 2022 | 5.38 Mn |